
During pregnancy, physiological changes in the immune response make pregnant women more susceptible to serious infection, increasing the risk for the mother as well as the foetus, newborn and infant. All women should be correctly and fully vaccinated as they enter their reproductive years, especially against diseases such as tetanus, hepatitis B, measles, rubella and varicella. In addition to the recommended vaccines, in risk situations, inactivated vaccines could be administered to women who were not correctly vaccinated before, while attenuated vaccines are contraindicated. Despite the fact that vaccination during pregnancy is a very important preventive measure and the existing recommendations from public health authorities, scientific societies and health professionals, the vaccination coverage could clearly be improved, especially against influenza and SARS-CoV-2, so any health professional involved in the care of pregnant women should proactively recommend these vaccines. The Spanish Association of Pediatrics (AEP), through its Advisory Committee on Vaccines, and the Spanish Society of Gynaecology and Obstetrics (SEGO) recommend vaccination against the following diseases during pregnancy: against influenza and COVID-19, in any trimester of pregnancy and during the postpartum period (up to 6 months post birth) in women not vaccinated during pregnancy; against pertussis, with the Tdap vaccine, between weeks 27 and 36 of gestation (in the CAV-AEP recommendations, preferably between weeks 27 and 28); and against RSV, with RSVPreF, between weeks 24 and 36 of gestation, preferably between weeks 32 and 36.
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunoterapia activa::vacunación, COVID-19 Vaccines, VRS E, Embarazo, Grip - Prevenció, Gripe, Embaràs, Pediatrics, RJ1-570, Pregnancy, Influenza, Human, FENÓMENOS Y PROCESOS::fenómenos fisiológicos reproductivos y urinarios::fenómenos fisiológicos de la reproducción::reproducción::embarazo, Humans, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Orthomyxoviridae::gripe humana, Vacunació, Other subheadings::Other subheadings::Other subheadings::/prevention & control, Pregnancy Complications, Infectious, ORGANISMOS::virus::virus ARN::Nidovirales::Coronaviridae::coronavirus, Otros calificadores::Otros calificadores::Otros calificadores::/prevención & control, SARS-CoV-2, COVID-19 (Malaltia) - Prevenció, ORGANISMS::Viruses::RNA Viruses::Nidovirales::Coronaviridae::Coronavirus, Vaccination, Vacunación, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunotherapy, Active::Vaccination, COVID-19, PHENOMENA AND PROCESSES::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproduction::Pregnancy, ORGANISMS::Viruses::RNA Viruses::Orthomyxoviridae::Influenzavirus A::Influenza A virus, Tosferina, Influenza Vaccines, Female
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunoterapia activa::vacunación, COVID-19 Vaccines, VRS E, Embarazo, Grip - Prevenció, Gripe, Embaràs, Pediatrics, RJ1-570, Pregnancy, Influenza, Human, FENÓMENOS Y PROCESOS::fenómenos fisiológicos reproductivos y urinarios::fenómenos fisiológicos de la reproducción::reproducción::embarazo, Humans, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Orthomyxoviridae::gripe humana, Vacunació, Other subheadings::Other subheadings::Other subheadings::/prevention & control, Pregnancy Complications, Infectious, ORGANISMOS::virus::virus ARN::Nidovirales::Coronaviridae::coronavirus, Otros calificadores::Otros calificadores::Otros calificadores::/prevención & control, SARS-CoV-2, COVID-19 (Malaltia) - Prevenció, ORGANISMS::Viruses::RNA Viruses::Nidovirales::Coronaviridae::Coronavirus, Vaccination, Vacunación, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunotherapy, Active::Vaccination, COVID-19, PHENOMENA AND PROCESSES::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproduction::Pregnancy, ORGANISMS::Viruses::RNA Viruses::Orthomyxoviridae::Influenzavirus A::Influenza A virus, Tosferina, Influenza Vaccines, Female
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 5 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
